Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma
type: MedicalStudy
description: Phase 2 Study of Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma
status: RECRUITING
study design: INTERVENTIONAL
phase: PHASE2
start date: 2026-01-07
end date: 2031-01-07
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT06919939
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: University of Miami
study subject: Large B-cell Lymphoma
study subject: Relapse
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: RECRUITING
keywords: Large B-cell Lymphoma
keywords: Relapse

AI Analytics
type: Organization